dapivirine has been researched along with baricitinib in 1 studies
Studies (dapivirine) | Trials (dapivirine) | Recent Studies (post-2010) (dapivirine) | Studies (baricitinib) | Trials (baricitinib) | Recent Studies (post-2010) (baricitinib) |
---|---|---|---|---|---|
196 | 64 | 160 | 653 | 95 | 631 |
Protein | Taxonomy | dapivirine (IC50) | baricitinib (IC50) |
---|---|---|---|
Cyclin-G-associated kinase | Homo sapiens (human) | 0.136 | |
Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 0.1233 | |
Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 0.0739 | |
Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | 0.1565 | |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.4477 | |
AP2-associated protein kinase 1 | Homo sapiens (human) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for dapivirine and baricitinib
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |